Moneycontrol
HomeNewsBusinessNetflix Q1 forecast erases much of stock’s pandemic gains

Netflix Q1 forecast erases much of stock’s pandemic gains

Netflix said the competition “may affect our marginal growth somewhat” but added that it is still growing in every country where new streaming options have been launched.

January 21, 2022 / 08:48 IST
Story continues below Advertisement
Representative image.

Netflix Inc has shattered hopes of a quick recovery after forecasting weak first-quarter subscriber growth on Thursday, sending shares down nearly 20% and wiping out most of the remaining profits caused by the pandemic since 2020.

The world’s largest streaming service predicted it would add 2.5 million customers between January and March, less than half of the 5.9 million predicted by analysts, according to data from Refinitiv IBES.

Story continues below Advertisement

Netflix toned down its growth expectations, citing the late release of expected content such as the second season of Bridgerton and Ryan Reynolds’ time-travel film Project Adam.

Shares of Netflix fell almost 20% to $408.13 after hours. Shares of rival Walt Disney Co (DIS.N), which has bet on building a strong streaming business, fell 4%. Streaming device Roku Inc (ROKU.O) fell 5%.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show